![](/img/cover-not-exists.png)
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide
Hata, Nobuhiro, Mizoguchi, Masahiro, Kuga, Daisuke, Hatae, Ryusuke, Akagi, Yojiro, Sangatsuda, Yuhei, Amemiya, Takeo, Michiwaki, Yuhei, Fujioka, Yutaka, Takigawa, Kosuke, Suzuki, Satoshi O., YoshitakeVolume:
146
Language:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-019-03339-0
Date:
February, 2020
File:
PDF, 1.40 MB
english, 2020